Motif Bio plc is a clinical-stage biopharmaceutical company. The Company is engaged in development of antibiotics, which are designed for treatment of infections caused by multi-drug resistant bacteria. It operates in the development and commercialization of pharmaceutical formulations segment. The Company is focused on development of its product, Iclaprim, for the treatment of the bacterial infections, such as acute bacterial skin and skin structure infections (ABSSSI) and hospital acquired bacterial pneumonia (HABP), including those caused by resistant strains, such as methicillin-resistant Staphylococcus aureus (MRSA) and multi-drug resistant Streptococcus pneumonia (MDRSP). Iclaprim exhibits potent activity against Gram-positive clinical isolates of various genera of staphylococci. It intends to build a portfolio of antibiotics by licensing drug candidates from organizations specializing in antibacterial research, and is pursuing programs in various stages of development.
Industry, Sector and Symbol:
- Sector: N/A
- Industry: N/A
- Sub-Industry: N/A
- Symbol: LON:MTFB
- CUSIP: N/A
- Web: N/A
- Market Cap: £61.7 million
- Outstanding Shares: 195,885,000
- 50 Day Moving Avg: GBX 32.97
- 200 Day Moving Avg: GBX 27.47
- 52 Week Range: GBX 21.44 - GBX 68.25
Sales & Book Value:
- Trailing P/E Ratio: N/A
- P/E Growth: 0.0000
- Annual Revenue: N/A
- Price / Sales: N/A
- Book Value: GBX 0.05 per share
- Price / Book: 6.30
- Average Volume: 1.74 million shs.
Frequently Asked Questions for Motif Bio PLC (LON:MTFB)
What is Motif Bio PLC's stock symbol?
Motif Bio PLC trades on the London Stock Exchange (LON) under the ticker symbol "MTFB."
Where is Motif Bio PLC's stock going? Where will Motif Bio PLC's stock price be in 2017?
4 analysts have issued 1-year price objectives for Motif Bio PLC's stock. Their predictions range from GBX 90 to GBX 125. On average, they expect Motif Bio PLC's stock price to reach GBX 108.33 in the next year. View Analyst Ratings for Motif Bio PLC.
Who are some of Motif Bio PLC's key competitors?
Some companies that are related to Motif Bio PLC include Carr's Group PLC (CRM), MaxCyte (MXCT), Moss Bros Group plc (MOSB), Hansard Global plc (HSD), Berkeley Energia Ltd (BKY), Cello Group plc (CLL), Wireless Group PLC (UTV), Mariana Resources (MARL), Churchill China plc (CHH), Eckoh PLC (ECK), Tissue Regenix Group PLC (TRX), Earthport plc (EPO), Real Estate Investors PLC. (RLE), Summit Therapeutics PLC (SUMM), Wynnstay Group plc (WYN), Sdx Energy Inc. Com (SDX), HSS Hire Group PLC (HSS) and Gresham Technologies PLC (GHT).
How do I buy Motif Bio PLC stock?
Shares of Motif Bio PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
How much does a share of Motif Bio PLC stock cost?
One share of Motif Bio PLC stock can currently be purchased for approximately GBX 31.50.
Earnings History for Motif Bio PLC (LON:MTFB)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Motif Bio PLC (LON:MTFB)
Current Year EPS Consensus Estimate: $-25.11 EPS
Dividend History for Motif Bio PLC (LON:MTFB)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Motif Bio PLC (LON:MTFB)Insider Trades by Quarter for Motif Bio PLC (LON:MTFB)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|10/5/2015||Stakes III,John Wilbur||Insider||Buy||100,000||GBX 60||£60,000|
Headline Trends for Motif Bio PLC (LON:MTFB)
Latest Headlines for Motif Bio PLC (LON:MTFB)
Motif Bio PLC (MTFB) Chart for Thursday, May, 25, 2017